Literature DB >> 24611117

Analysis of Campylobacter jejuni isolates of various sources for loci associated with Guillain-Barré Syndrome.

P Amon, D Klein, B Springer, S Jelovcan, D Sofka, F Hilbert.   

Abstract

Campylobacter jejuni is a major cause of the Guillain-Barré syndrome (GBS) and related diseases. These autoimmune diseases are caused by antibodies cross-reacting with the peripheral (GBS) and central neural tissue (Miller Fisher syndrome - MFS, Bicker-staff's brainstem encephalitis - BBE), leading to acute polyneuropathy. Recently, specific gene loci in C. jejuni have been distinguished which are associated with the onset of GBS, despite a molecular or phenotypic clustering. In this study, we used PCR to analyse C. jejuni isolates of different origin (i.e. bovine, poultry, human) for these genes. A total of 196 isolates were tested for cst-II and neuA. Of these, 101 isolates harboured the cst-II locus and 102 the neuA locus. Eighty-six isolates (44%) hold both genes. The frequency of cst-II in different sources of isolates of bovine, poultry and human isolates did not vary significantly (52, 50 and 52%, respectively). In contrast, the neuA locus was less often found in poultry isolates. Two human strains - from a family outbreak of campylobacteriosis (in 1989 in Austria) in which one person developed MFS - harboured both genes. Thus, although only one in more than 3000 patients with Campylobacter-associated enteritis develop GBS, about half of Campylobacter jejuni strains found in different environments are possibly able to cause GBS. These strains almost equally distributed in bovine, poultry and human isolates. Our results suggest that isolates associated with GBS are not selected by environmental or host-specific factors. Accordingly, this study indicates that host factors such as humoral and cellular immunity are possibly responsible for the development of these autoimmune diseases.

Entities:  

Keywords:  Campylobacter jejuni; Guillain-Barré syndrome; cattle; cst-II; meat; neuA; poultry

Year:  2012        PMID: 24611117      PMCID: PMC3933986          DOI: 10.1556/EuJMI.2.2012.1.4

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  21 in total

Review 1.  Epidemiology of Campylobacter enteritis.

Authors:  M B Skirrow
Journal:  Int J Food Microbiol       Date:  1991-01       Impact factor: 5.277

2.  TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.

Authors:  Mark L Kuijf; Janneke N Samsom; Wouter van Rijs; Marieke Bax; Ruth Huizinga; Astrid P Heikema; Pieter A van Doorn; Alex van Belkum; Yvette van Kooyk; Peter C Burgers; Theo M Luider; Hubert P Endtz; Edward E S Nieuwenhuis; Bart C Jacobs
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

3.  Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.

Authors:  Craig T Parker; Sharon T Horn; Michel Gilbert; William G Miller; David L Woodward; Robert E Mandrell
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.

Authors:  M Koga; M Takahashi; M Masuda; K Hirata; N Yuki
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

5.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  Campylobacter jejuni infection and Guillain-Barré syndrome.

Authors:  J H Rees; S E Soudain; N A Gregson; R A Hughes
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

Review 7.  Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki
Journal:  J Neurochem       Date:  2007-11       Impact factor: 5.372

8.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.

Authors:  S Kuroki; T Saida; M Nukina; T Haruta; M Yoshioka; Y Kobayashi; H Nakanishi
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

Review 9.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more
  2 in total

1.  Prevalence of virulence genes in strains of Campylobacter jejuni isolated from human, bovine and broiler.

Authors:  Gisela González-Hein; Bernardo Huaracán; Patricia García; Guillermo Figueroa
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

2.  Whole Genome Sequencing and Multiplex qPCR Methods to Identify Campylobacter jejuni Encoding cst-II or cst-III Sialyltransferase.

Authors:  Jason M Neal-McKinney; Kun C Liu; Karen C Jinneman; Wen-Hsin Wu; Daniel H Rice
Journal:  Front Microbiol       Date:  2018-03-16       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.